Clinical Trial Update: Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of cetuximab and irinotecan for advanced colorectal cancer has completed, sponsored by the University of Alabama at B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• ERBITUX (cetuximab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED